Global Adoptive?Cellular?Immunotherapy Market Research Report 2021 Forecast to 2026

Code: RW00014532474
Multimarket Insight
Oct-2021
Life Sciences
180 Pages

Adoptive immunotherapy?involves administration of immune effector cells into a patient to produce antitumor effects.?
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.

Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Adoptive?Cellular?Immunotherapy industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.

Market Segment by Product Type
TIL
LAK
CAR-T
TCR-T
CIK
NK
DC
Other

Market Segment by Product Application
Hospital
Cancer Hospital
Centers for Disease Control and Prevention
Rehabilitation Center
Other

Finally, the report provides detailed profile and data information analysis of leading company.
Amgen Inc
Autolus Therapeutics Plc
Beijing Immunochina Medical Science & Technology Co Ltd
Bellicum Pharmaceuticals Inc
Bristol-Myers Squibb Co
bluebird bio Inc
CARsgen Therapeutics Ltd
Celgene Corp
Cell Medica Ltd
Cellular Biomedicine Group Inc
Celularity Inc
Celyad SA
Daiichi Sankyo Co Ltd
Fosun Pharmaceutical AG
Gilead Sciences Inc
Guangzhou Anjie Biomedical Technology Co Ltd
Hangzhou Converd Co Ltd
Hebei Senlang Biotechnology Inc Ltd
HRAIN Biotechnology Co Ltd
Juno Therapeutics Inc
Kite Pharma Inc
Nanjing Legend Biotech Co Ltd
NantKwest Inc
Nkarta Inc
Novartis AG
Ono Pharmaceutical Co Ltd
Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
Sorrento Therapeutics Inc
Takara Bio Inc

Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.

Research Objectives
1.To study and analyze the global Adoptive?Cellular?Immunotherapy consumption (value) by key regions/countries, product type and application, history data from 2016 to 2020, and forecast to 2026.
2.To understand the structure of Adoptive?Cellular?Immunotherapy market by identifying its various subsegments.
3.Focuses on the key global Adoptive?Cellular?Immunotherapy manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Adoptive?Cellular?Immunotherapy with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Adoptive?Cellular?Immunotherapy submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

Global Adoptive?Cellular?Immunotherapy Market Research Report 2021, Forecast to 2026

1 Market Study Overview
1.1 Study Objectives
1.2 Adoptive?Cellular?Immunotherapy Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation

2 Global Trend Summary
2.1 Adoptive?Cellular?Immunotherapy Segment by Type
2.1.1 TIL
2.1.2 LAK
2.1.3 CAR-T
2.1.4 TCR-T
2.1.5 CIK
2.1.6 NK
2.1.7 DC
2.1.8 Other
2.2 Market Analysis by Application
2.2.1 Hospital
2.2.2 Cancer Hospital
2.2.3 Centers for Disease Control and Prevention
2.2.4 Rehabilitation Center
2.2.5 Other
2.3 Global Adoptive?Cellular?Immunotherapy Market Comparison by Regions (2016-2026)
2.3.1 Global Adoptive?Cellular?Immunotherapy Market Size (2016-2026)
2.3.2 North America Adoptive?Cellular?Immunotherapy Status and Prospect (2016-2026)
2.3.3 Europe Adoptive?Cellular?Immunotherapy Status and Prospect (2016-2026)
2.3.4 China Adoptive?Cellular?Immunotherapy Status and Prospect (2016-2026)
2.3.5 Japan Adoptive?Cellular?Immunotherapy Status and Prospect (2016-2026)
2.3.6 Southeast Asia Adoptive?Cellular?Immunotherapy Status and Prospect (2016-2026)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Adoptive?Cellular?Immunotherapy Industry Impact
2.5.1 Adoptive?Cellular?Immunotherapy Business Impact Assessment - Covid-19
2.5.2 Market Trends and Adoptive?Cellular?Immunotherapy Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19

3 Competition by Manufacturer
3.1 Global Adoptive?Cellular?Immunotherapy Sales and Market Share by Manufacturer (2016-2021)
3.2 Global Adoptive?Cellular?Immunotherapy Revenue and Market Share by Manufacturer (2016-2021)
3.3 Global Adoptive?Cellular?Immunotherapy Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Adoptive?Cellular?Immunotherapy Manufacturer Market Share
3.5 Top 10 Adoptive?Cellular?Immunotherapy Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Adoptive?Cellular?Immunotherapy Market
3.7 Key Manufacturers Adoptive?Cellular?Immunotherapy Key Manufacturers
3.8 Mergers & Acquisitions Planning

4 Analysis of Adoptive?Cellular?Immunotherapy Industry Key Manufacturers
4.1 Amgen Inc
4.1.1 Compan Detail
4.1.2 Amgen Inc Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification
4.1.3 Amgen Inc 180 Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.1.4 Main Business Overview
4.1.5 Amgen Inc News
4.2 Autolus Therapeutics Plc
4.2.1 Compan Detail
4.2.2 Autolus Therapeutics Plc Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification
4.2.3 Autolus Therapeutics Plc Adoptive?Cellular?Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.2.4 Main Business Overview
4.2.5 Amgen Inc News
4.3 Beijing Immunochina Medical Science & Technology Co Ltd
4.3.1 Compan Detail
4.3.2 Beijing Immunochina Medical Science & Technology Co Ltd Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification
4.3.3 Beijing Immunochina Medical Science & Technology Co Ltd Adoptive?Cellular?Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.3.4 Main Business Overview
4.3.5 Beijing Immunochina Medical Science & Technology Co Ltd News
4.4 Bellicum Pharmaceuticals Inc
4.4.1 Compan Detail
4.4.2 Bellicum Pharmaceuticals Inc Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification
4.4.3 Bellicum Pharmaceuticals Inc Adoptive?Cellular?Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.4.4 Main Business Overview
4.4.5 Bellicum Pharmaceuticals Inc News
4.5 Bristol-Myers Squibb Co
4.5.1 Compan Detail
4.5.2 Bellicum Pharmaceuticals Inc Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification
4.5.3 Bristol-Myers Squibb Co Adoptive?Cellular?Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.5.4 Main Business Overview
4.5.5 Bristol-Myers Squibb Co News
4.6 bluebird bio Inc
4.6.1 Compan Detail
4.6.2 bluebird bio Inc Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification
4.6.3 bluebird bio Inc Adoptive?Cellular?Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.6.4 Main Business Overview
4.6.5 bluebird bio Inc News
4.7 CARsgen Therapeutics Ltd
4.7.1 Compan Detail
4.7.2 CARsgen Therapeutics Ltd Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification
4.7.3 CARsgen Therapeutics Ltd Adoptive?Cellular?Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Celgene Corp
4.8.1 Compan Detail
4.8.2 Celgene Corp Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification
4.8.3 Celgene Corp Adoptive?Cellular?Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.8.4 Main Business Overview
4.8.5 Celgene Corp News
4.9 Cell Medica Ltd
4.9.1 Compan Detail
4.9.2 Cell Medica Ltd Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification
4.9.3 Cell Medica Ltd Adoptive?Cellular?Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.9.4 Main Business Overview
4.9.5 Cell Medica Ltd News
4.10 Cellular Biomedicine Group Inc
4.10.1 Compan Detail
4.10.2 Cellular Biomedicine Group Inc Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification
4.10.3 Cellular Biomedicine Group Inc Adoptive?Cellular?Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.10.4 Main Business Overview
4.10.5 Cellular Biomedicine Group Inc News
4.11 Celularity Inc
4.11.1 Compan Detail
4.11.2 Celularity Inc Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification
4.11.3 Celularity Inc Adoptive?Cellular?Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.11.4 Main Business Overview
4.11.5 Celularity Inc News
4.12 Celyad SA
4.12.1 Compan Detail
4.12.2 Celyad SA Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification
4.12.3 Celyad SA Adoptive?Cellular?Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.12.4 Main Business Overview
4.12.5 Celyad SA News
4.13 Daiichi Sankyo Co Ltd
4.13.1 Company Details
4.13.2 Daiichi Sankyo Co Ltd Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification
4.13.3 Daiichi Sankyo Co Ltd Adoptive?Cellular?Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.13.4 Main Business Overview
4.13.5 Daiichi Sankyo Co Ltd News
4.14 Fosun Pharmaceutical AG
4.14.1 Compan Detail
4.14.2 Fosun Pharmaceutical AG Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification
4.14.3 Fosun Pharmaceutical AG Adoptive?Cellular?Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.14.4 Main Business Overview
4.14.5 Fosun Pharmaceutical AG News
4.15 Gilead Sciences Inc
4.15.1 Compan Detail
4.15.2 Gilead Sciences Inc Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification
4.15.3 Gilead Sciences Inc Adoptive?Cellular?Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.15.4 Main Business Overview
4.15.5 Gilead Sciences Inc News
4.16 Guangzhou Anjie Biomedical Technology Co Ltd
4.16.1 Compan Detail
4.16.2 Guangzhou Anjie Biomedical Technology Co Ltd Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification
4.16.3 Guangzhou Anjie Biomedical Technology Co Ltd Adoptive?Cellular?Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.16.4 Main Business Overview
4.16.5 Guangzhou Anjie Biomedical Technology Co Ltd News
4.17 Hangzhou Converd Co Ltd
4.17.1 Compan Detail
4.17.2 Hangzhou Converd Co Ltd Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification
4.17.3 Hangzhou Converd Co Ltd Adoptive?Cellular?Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.17.4 Main Business Overview
4.17.5 Hangzhou Converd Co Ltd News
4.18 Hebei Senlang Biotechnology Inc Ltd
4.18.1 Compan Detail
4.18.2 Hebei Senlang Biotechnology Inc Ltd Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification
4.18.3 Hebei Senlang Biotechnology Inc Ltd Adoptive?Cellular?Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.18.4 Main Business Overview
4.18.5 Hebei Senlang Biotechnology Inc Ltd News
4.19 HRAIN Biotechnology Co Ltd
4.19.1 Compan Detail
4.19.2 HRAIN Biotechnology Co Ltd Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification
4.19.3 HRAIN Biotechnology Co Ltd Adoptive?Cellular?Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.19.4 Main Business Overview
4.19.5 HRAIN Biotechnology Co Ltd News
4.20 Juno Therapeutics Inc
4.20.1 Compan Detail
4.20.2 Juno Therapeutics Inc Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification
4.20.3 Juno Therapeutics Inc Adoptive?Cellular?Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.20.4 Main Business Overview
4.20.5 Juno Therapeutics Inc News
4.21 Kite Pharma Inc
4.21.1 Compan Detail
4.21.2 Kite Pharma Inc Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification
4.21.3 Kite Pharma Inc Adoptive?Cellular?Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.21.4 Main Business Overview
4.21.5 Kite Pharma Inc News
4.22 Nanjing Legend Biotech Co Ltd
4.22.1 Compan Detail
4.22.2 Nanjing Legend Biotech Co Ltd Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification
4.22.3 Nanjing Legend Biotech Co Ltd Adoptive?Cellular?Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.22.4 Main Business Overview
4.22.5 Nanjing Legend Biotech Co Ltd News
4.23 NantKwest Inc
4.23.1 Compan Detail
4.23.2 NantKwest Inc Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification
4.23.3 NantKwest Inc Adoptive?Cellular?Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.23.4 Main Business Overview
4.23.5 NantKwest Inc News
4.24 Nkarta Inc
4.24.1 Compan Detail
4.24.2 Nkarta Inc Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification
4.24.3 Nkarta Inc Adoptive?Cellular?Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.24.4 Main Business Overview
4.24.5 Nkarta Inc News
4.25 Novartis AG
4.25.1 Compan Detail
4.25.2 Novartis AG Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification
4.25.3 Novartis AG Adoptive?Cellular?Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.25.4 Main Business Overview
4.25.5 Novartis AG News
4.26 Ono Pharmaceutical Co Ltd
4.26.1 Compan Detail
4.26.2 Ono Pharmaceutical Co Ltd Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification
4.26.3 Ono Pharmaceutical Co Ltd Adoptive?Cellular?Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.26.4 Main Business Overview
4.26.5 Ono Pharmaceutical Co Ltd News
4.27 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
4.27.1 Compan Detail
4.27.2 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification
4.27.3 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Adoptive?Cellular?Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.27.4 Main Business Overview
4.27.5 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd News
4.28 Sorrento Therapeutics Inc
4.28.1 Compan Detail
4.28.2 Sorrento Therapeutics Inc Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification
4.28.3 Sorrento Therapeutics Inc Adoptive?Cellular?Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.28.4 Main Business Overview
4.28.5 Sorrento Therapeutics Inc News
4.29 Takara Bio Inc
4.29.1 Compan Detail
4.29.2 Takara Bio Inc Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification
4.29.3 Takara Bio Inc Adoptive?Cellular?Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.29.4 Main Business Overview
4.29.5 Takara Bio Inc News

5 Global Adoptive?Cellular?Immunotherapy Market Segment by Big Type
5.1 Global Adoptive?Cellular?Immunotherapy Revenue, Sales and Market Share by Big Type (2016-2021)
5.1.1 Global Adoptive?Cellular?Immunotherapy Sales and Market Share by Big Type (2016-2021)
5.1.2 Global Adoptive?Cellular?Immunotherapy Revenue and Market Share by Big Type (2016-2021)
5.2 TIL Sales Growth Rate and Price
5.2.1 Global TIL Sales Growth Rate (2016-2021)
5.2.2 Global TIL Price (2016-2021)
5.3 LAK Sales Growth Rate and Price
5.3.1 Global LAK Sales Growth Rate (2016-2021)
5.3.2 Global LAK Price (2016-2021)
5.4 CAR-T Sales Growth Rate and Price
5.4.1 Global CAR-T Sales Growth Rate (2016-2021)
5.4.2 Global CAR-T Price (2016-2021)
5.5 TCR-T Sales Growth Rate and Price
5.5.1 Global TCR-T Sales Growth Rate (2016-2021)
5.5.2 Global TCR-T Price (2016-2021)
5.6 CIK Sales Growth Rate and Price
5.6.1 Global CIK Sales Growth Rate (2016-2021)
5.6.2 Global CIK Price (2016-2021)
5.7 NK Sales Growth Rate and Price
5.7.1 Global NK Sales Growth Rate (2016-2021)
5.7.2 Global NK Price (2016-2021)
5.8 DC Sales Growth Rate and Price
5.8.1 Global DC Sales Growth Rate (2016-2021)
5.8.2 Global DC Price (2016-2021)
5.9 Other Sales Growth Rate and Price
5.9.1 Global Other Sales Growth Rate (2016-2021)
5.9.2 Global Other Price (2016-2021)

6 Global Adoptive?Cellular?Immunotherapy Market Segment by Big Application
6.1 Global Adoptive?Cellular?Immunotherapy Sales Market Share by Big Application (2016-2021)
6.2 Hospital Sales Growth Rate (2016-2021)
6.3 Cancer Hospital Sales Growth Rate (2016-2021)
6.4 Centers for Disease Control and Prevention Sales Growth Rate (2016-2021)
6.5 Rehabilitation Center Sales Growth Rate (2016-2021)
6.6 Other Sales Growth Rate (2016-2021)

7 Global Adoptive?Cellular?Immunotherapy Forecast
7.1 Global Adoptive?Cellular?Immunotherapy Revenue, Sales and Growth Rate (2021-2026)
7.2 Adoptive?Cellular?Immunotherapy Market Forecast by Regions (2021-2026)
7.2.1 North America Adoptive?Cellular?Immunotherapy Market Forecast (2021-2026)
7.2.2 Europe Adoptive?Cellular?Immunotherapy Market Forecast (2021-2026)
7.2.3 China Adoptive?Cellular?Immunotherapy Market Forecast (2021-2026)
7.2.4 Japan Adoptive?Cellular?Immunotherapy Market Forecast (2021-2026)
7.2.5 Southeast Asia Adoptive?Cellular?Immunotherapy Market Forecast (2021-2026)
7.2.6 Other Regions Adoptive?Cellular?Immunotherapy Market Forecast (2021-2026)
7.3 Adoptive?Cellular?Immunotherapy Market Forecast by Type (2021-2026)
7.3.1 Global Adoptive?Cellular?Immunotherapy Sales Forecast by Type (2021-2026)
7.3.2 Global Adoptive?Cellular?Immunotherapy Market Share Forecast by Type (2021-2026)
7.4 Adoptive?Cellular?Immunotherapy Market Forecast by Application (2021-2026)
7.4.1 Global Adoptive?Cellular?Immunotherapy Sales Forecast by Application (2021-2026)
7.4.2 Global Adoptive?Cellular?Immunotherapy Market Share Forecast by Application (2021-2026)

8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis

9 Adoptive?Cellular?Immunotherapy Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Adoptive?Cellular?Immunotherapy Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers

10 Research Findings and Conclusion

List of Tables and Figures

Figure Product Picture Adoptive?Cellular?Immunotherapy
Figure Market Concentration Ratio and Market Maturity Analysis of Adoptive?Cellular?Immunotherapy
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Adoptive?Cellular?Immunotherapy Market Size by Big Type
Figure Global Market Share of Adoptive?Cellular?Immunotherapy by Big Type in 2020
Figure TIL Picture (2016-2021)
Figure LAK Picture (2016-2021)
Figure CAR-T Picture (2016-2021)
Figure TCR-T Picture (2016-2021)
Figure CIK Picture (2016-2021)
Figure NK Picture (2016-2021)
Figure DC Picture (2016-2021)
Global Adoptive?Cellular?Immunotherapy Market Size by Big Application
Table Global Adoptive?Cellular?Immunotherapy Market Size by Application
Figure Global Adoptive?Cellular?Immunotherapy Market Share by Big Application in 2020
Figure Hospital Picture
Figure Cancer Hospital Picture
Figure Centers for Disease Control and Prevention Picture
Figure Rehabilitation Center Picture
Figure Other Picture
Table Global Adoptive?Cellular?Immunotherapy Comparison by Regions (M USD) ?2016-2026?
Figure Global Adoptive?Cellular?Immunotherapy Market Size (Million US$) (2016-2026)
Figure North America Adoptive?Cellular?Immunotherapy Revenue (Million US$) Growth Rate (2016-2026)
Figure Europe Adoptive?Cellular?Immunotherapy Revenue (Million US$) Growth Rate (2016-2026)
Figure China Adoptive?Cellular?Immunotherapy Revenue (Million US$) Growth Rate (2016-2026)
Figure Japan Adoptive?Cellular?Immunotherapy Revenue (Million US$) Growth Rate (2016-2026)
Figure Southeast Asia Adoptive?Cellular?Immunotherapy Revenue (Million US$) Growth Rate (2016-2026)
Table Business Impact Assessment - Covid-19
Table Market Trends and Adoptive?Cellular?Immunotherapy Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Adoptive?Cellular?Immunotherapy Sales by Manufacturer (2016-2021)
Figure Global Adoptive?Cellular?Immunotherapy Sales Market Share by Manufacturer in 2020
Table Global Adoptive?Cellular?Immunotherapy Revenue by Manufacturer (2016-2021)
Figure Global Adoptive?Cellular?Immunotherapy Revenue Market Share by Manufacturer in 2020
Table Global Adoptive?Cellular?Immunotherapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Adoptive?Cellular?Immunotherapy Manufacturer (Revenue) Market Share in 2020
Figure Top 10 Adoptive?Cellular?Immunotherapy Manufacturer (Revenue) Market Share in 2020
Table Date of Key Manufacturers Enter into Adoptive?Cellular?Immunotherapy Market
Table Key Manufacturers Adoptive?Cellular?Immunotherapy Product Type
Table Mergers & Acquisitions Planning
Table Amgen Inc Company Profile
Table Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification of Amgen Inc
Table Adoptive?Cellular?Immunotherapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2016-2021
Table Company One Main Business
Table Company One Recent Development
Table Autolus Therapeutics Plc Company Profile
Table Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification of Autolus Therapeutics Plc
Table Adoptive?Cellular?Immunotherapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Autolus Therapeutics Plc Recent Development
Table Beijing Immunochina Medical Science & Technology Co Ltd Company Profile
Table Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification of Beijing Immunochina Medical Science & Technology Co Ltd
Table Adoptive?Cellular?Immunotherapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Beijing Immunochina Medical Science & Technology Co Ltd Main Business
Table Beijing Immunochina Medical Science & Technology Co Ltd Recent Development
Table Bellicum Pharmaceuticals Inc Company Profile
Table Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification of Bellicum Pharmaceuticals Inc
Table Adoptive?Cellular?Immunotherapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Bellicum Pharmaceuticals Inc Main Business
Table Bellicum Pharmaceuticals Inc Recent Development
Table Bellicum Pharmaceuticals Inc Main Business
Table Bellicum Pharmaceuticals Inc Recent Development
Table Bristol-Myers Squibb Co Company Profile
Table Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification of Bristol-Myers Squibb Co
Table Adoptive?Cellular?Immunotherapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Bristol-Myers Squibb Co Main Business
Table Bristol-Myers Squibb Co Recent Development
Table bluebird bio Inc Company Profile
Table Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification of bluebird bio Inc
Table Adoptive?Cellular?Immunotherapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table bluebird bio Inc Main Business
Table bluebird bio Inc Recent Development
Table CARsgen Therapeutics Ltd Company Profile
Table Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification of CARsgen Therapeutics Ltd
Table Adoptive?Cellular?Immunotherapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table CARsgen Therapeutics Ltd Main Business
Table CARsgen Therapeutics Ltd Recent Development
Table Celgene Corp Company Profile
Table Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification of Celgene Corp
Table Adoptive?Cellular?Immunotherapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Celgene Corp Main Business
Table Celgene Corp Recent Development
Table Cell Medica Ltd Company Profile
Table Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification of Cell Medica Ltd
Table Adoptive?Cellular?Immunotherapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Cell Medica Ltd Main Business
Table Cell Medica Ltd Recent Development
Table Cellular Biomedicine Group Inc Company Profile
Table Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification of Cellular Biomedicine Group Inc
Table Adoptive?Cellular?Immunotherapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Cellular Biomedicine Group Inc Main Business
Table Cellular Biomedicine Group Inc Recent Development
Table Celularity Inc Company Profile
Table Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification of Celularity Inc
Table Adoptive?Cellular?Immunotherapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Celularity Inc Main Business
Table Celularity Inc Recent Development
Table Celyad SA Company Profile
Table Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification of Celyad SA
Table Adoptive?Cellular?Immunotherapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Celyad SA Main Business
Table Celyad SA Recent Development
Table Daiichi Sankyo Co Ltd Company Profile
Table Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification of Daiichi Sankyo Co Ltd
Table Adoptive?Cellular?Immunotherapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Daiichi Sankyo Co Ltd Main Business
Table Daiichi Sankyo Co Ltd Recent Development
Table Fosun Pharmaceutical AG Company Profile
Table Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification of Fosun Pharmaceutical AG
Table Adoptive?Cellular?Immunotherapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Fosun Pharmaceutical AG Main Business
Table Fosun Pharmaceutical AG Recent Development
Table Guangzhou Anjie Biomedical Technology Co Ltd Company Profile
Table Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification of Guangzhou Anjie Biomedical Technology Co Ltd
Table Adoptive?Cellular?Immunotherapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Guangzhou Anjie Biomedical Technology Co Ltd Main Business
Table Guangzhou Anjie Biomedical Technology Co Ltd Recent Development
Table Hangzhou Converd Co Ltd Company Profile
Table Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification of Hangzhou Converd Co Ltd
Table Adoptive?Cellular?Immunotherapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Hangzhou Converd Co Ltd Main Business
Table Hangzhou Converd Co Ltd Recent Development
Table Hebei Senlang Biotechnology Inc Ltd Company Profile
Table Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification of Hebei Senlang Biotechnology Inc Ltd
Table Adoptive?Cellular?Immunotherapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Hebei Senlang Biotechnology Inc Ltd Main Business
Table Hebei Senlang Biotechnology Inc Ltd Recent Development
Table HRAIN Biotechnology Co Ltd Company Profile
Table Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification of HRAIN Biotechnology Co Ltd
Table Adoptive?Cellular?Immunotherapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table HRAIN Biotechnology Co Ltd Main Business
Table HRAIN Biotechnology Co Ltd Recent Development
Table Juno Therapeutics Inc Company Profile
Table Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification of Juno Therapeutics Inc
Table Adoptive?Cellular?Immunotherapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Juno Therapeutics Inc Main Business
Table Juno Therapeutics Inc Recent Development
Table Kite Pharma Inc Company Profile
Table Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification of Kite Pharma Inc
Table Adoptive?Cellular?Immunotherapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Kite Pharma Inc Main Business
Table Kite Pharma Inc Recent Development
Table Nanjing Legend Biotech Co Ltd Company Profile
Table Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification of Nanjing Legend Biotech Co Ltd
Table Adoptive?Cellular?Immunotherapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Nanjing Legend Biotech Co Ltd Main Business
Table Nanjing Legend Biotech Co Ltd Recent Development
Table NantKwest Inc Company Profile
Table Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification of NantKwest Inc
Table Adoptive?Cellular?Immunotherapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table NantKwest Inc Main Business
Table NantKwest Inc Recent Development
Table Nkarta Inc Company Profile
Table Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification of Nkarta Inc
Table Adoptive?Cellular?Immunotherapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Nkarta Inc Main Business
Table Nkarta Inc Recent Development
Table Novartis AG Company Profile
Table Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification of Novartis AG
Table Adoptive?Cellular?Immunotherapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Novartis AG Main Business
Table Novartis AG Recent Development
Table Ono Pharmaceutical Co Ltd Company Profile
Table Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification of Ono Pharmaceutical Co Ltd
Table Adoptive?Cellular?Immunotherapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Ono Pharmaceutical Co Ltd Main Business
Table Ono Pharmaceutical Co Ltd Recent Development
Table Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Company Profile
Table Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification of Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
Table Adoptive?Cellular?Immunotherapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Main Business
Table Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Recent Development
Table Sorrento Therapeutics Inc Company Profile
Table Adoptive?Cellular?Immunotherapy Product Introduction, Application and Specification of Sorrento Therapeutics Inc
Table Adoptive?Cellular?Immunotherapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Sorrento Therapeutics Inc Main Business
Table Sorrento Therapeutics Inc Recent Development
Table Takara Bio Inc C

Amgen Inc
Autolus Therapeutics Plc
Beijing Immunochina Medical Science & Technology Co Ltd
Bellicum Pharmaceuticals Inc
Bristol-Myers Squibb Co
bluebird bio Inc
CARsgen Therapeutics Ltd
Celgene Corp
Cell Medica Ltd
Cellular Biomedicine Group Inc
Celularity Inc
Celyad SA
Daiichi Sankyo Co Ltd
Fosun Pharmaceutical AG
Gilead Sciences Inc
Guangzhou Anjie Biomedical Technology Co Ltd
Hangzhou Converd Co Ltd
Hebei Senlang Biotechnology Inc Ltd
HRAIN Biotechnology Co Ltd
Juno Therapeutics Inc
Kite Pharma Inc
Nanjing Legend Biotech Co Ltd
NantKwest Inc
Nkarta Inc
Novartis AG
Ono Pharmaceutical Co Ltd
Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE